Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

9 treatments under study, led by Different Thoracic Surgical Approaches

Research Leaders

14 sponsors active, led by First Affiliated Hospital Xi'an Jiaotong University

Related Conditions

Often studied with 10 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 8 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

5Total
Not Applicable (4)
Phase 2 (1)

Trial Status

Recruiting4
Unknown3
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (8)

Research Network

Common Treatments

  • Different Thoracic Surgical Approaches1
  • Proximal Gastrectomy1
  • Endoscopy Ivorlewis1
  • Standard Of Care Preoperative Therapy1
  • Transthoracic Singlehole Assisted Laparoscopic Radical Gastrectomy For Siewert Type Ⅱ Adenocarcinoma Of Esophagogastric Junction1

Active Sponsors

  • First Affiliated Hospital Xi'an Jiaotong University1
  • General Hospital of Ningxia Medical University1
  • Guangdong Provincial Hospital of Traditional Chinese Medicine1
  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences1
  • Melissa Lumish1

Top Investigators

Related Conditions

  • Siewert Type Iii Adenocarcinoma Of Esophagogastric Junction3
  • Siewert Type I Adenocarcinoma Of Esophagogastric Junction2
  • Stomach Neoplasms1
  • Recurrence1
  • Adenocarcinoma Esophagus1

Activity Timeline